FAQs Address Coverage of PrEP, Related STI Screening and Hepatitis Testing, and More | Practical Law

FAQs Address Coverage of PrEP, Related STI Screening and Hepatitis Testing, and More | Practical Law

The Departments of Labor (DOL), Health and Human Services (HHS), and Treasury (collectively, Departments) issued FAQs addressing health plan coverage requirements for pre-exposure prophylaxis (PrEP). The FAQs clarify the scope of PrEP-related support services in light of the US Preventive Services Task Force's (USPSTF's) recent "A" rating recommendation that providers offer PrEP to persons who are at high risk of acquiring HIV.

FAQs Address Coverage of PrEP, Related STI Screening and Hepatitis Testing, and More

Practical Law Legal Update w-031-9554 (Approx. 4 pages)

FAQs Address Coverage of PrEP, Related STI Screening and Hepatitis Testing, and More

by Practical Law Employee Benefits & Executive Compensation
Published on 20 Jul 2021USA (National/Federal)
The Departments of Labor (DOL), Health and Human Services (HHS), and Treasury (collectively, Departments) issued FAQs addressing health plan coverage requirements for pre-exposure prophylaxis (PrEP). The FAQs clarify the scope of PrEP-related support services in light of the US Preventive Services Task Force's (USPSTF's) recent "A" rating recommendation that providers offer PrEP to persons who are at high risk of acquiring HIV.
In FAQ guidance (July 19, 2021), the DOL, HHS, and Treasury (Departments) have clarified how health plans and insurers must cover pre-exposure prophylaxis (PrEP) and related services under the Affordable Care Act's (ACA's) preventive health services rules. The FAQs expand on a US Preventive Services Task Force (USPSTF) "A" rating recommendation (issued June 11, 2019) that providers offer PrEP with "effective antiretroviral therapy" to individuals who are at high risk of acquiring human immunodeficiency virus (HIV) (see Practice Note, Preventive Health Services Under the ACA, Other Than Contraceptives: Preexposure Prophylaxis (PrEP)). As background, ACA implementing rules require non-grandfathered group health plans and health insurers to cover, without cost-sharing, evidence-based items or services that are recommended by the USPSTF with a rating of "A" or "B." Under the ACA's preventive health service rules, the USPSTF's PrEP recommendation applied to plans and insurers for plan years beginning on or after June 30, 2020.

Uncertainty Regarding PrEP-Related Services; Limited Nonenforcement Period

In issuing the FAQs, the Departments acknowledged that plans and insurers may not have understood that the USPSTF's June 2019 recommendation on PrEP also applies to coverage of PrEP-related support services. The FAQs therefore:
  • Clarify the scope of PrEP-related support services that must be covered under the June 2019 USPSTF recommendation.
  • Provide a 60-day nonenforcement period (measured from July 19, 2021) during which the Departments will not take enforcement action against plans or insurers that fail to cover PrEP-related support services as addressed in the FAQs.
Assuming calendar days, the Departments' limited nonenforcement period will end on September 17, 2021. The Departments encouraged the states to take a similar enforcement approach regarding coverage types under their jurisdiction.

Scope of PrEP-Related Support Services

The FAQs specify that plans and insurers must provide first-dollar coverage of items and services that the USPSTF has recommended participants and beneficiaries to receive before being prescribed PrEP. According to the Departments, these support items and services are part of the determination of whether PrEP is appropriate for that individual—and for ongoing follow-up and monitoring. The June 2019 USPSTF recommendation cited guidance from the Centers for Disease Control and Prevention (CDC), that listed a combination of baseline and monitoring services that enhance PrEP's efficacy. These support services:
  • Ensure that PrEP is given to individuals who are not infected with HIV (for whom it can lead to drug-resistant HIV infection) and who do not have medical contraindications.
  • Are used to monitor individuals who are taking the medication to ensure it is used safely.
The FAQs include the following six-part list of baseline and monitoring services that the Departments view as part of the PrEP recommendation:
  • HIV testing. Individuals should be tested to confirm that they do not have HIV prior to starting PrEP, should be tested for HIV every three months while taking PrEP, and should stop using PrEP if they become infected with HIV.
  • Hepatitis B and C testing.
  • Pregnancy testing.
  • Sexually transmitted infection (STI) screening and counseling. Required baseline testing for STIs may involve testing for gonorrhea, chlamydia, and syphilis—the presence of which may increase the chances of acquiring HIV sexually.
  • Creatinine testing and calculated estimated creatine clearance (eCrCl) or glomerular filtration rate (eGFR). This testing helps determine whether an individual's kidney function is in a range that is safe for PrEP to be prescribed.
  • Adherence counseling. Behavior and adherence counseling is intended to ensure that PrEP is used correctly to maximize its effectiveness.
Plans and insurers also must cover, without cost-sharing, office visits associated with each recommended preventive service for a participant or beneficiary when:
  • The service is not billed separately (or is not separately tracked as individual encounter data) from an office visit.
  • The visit's primary purpose is to deliver the recommended preventive service.

Use of Reasonable Medical Management

Plans or insurers may not use reasonable medical management techniques to limit the frequency of benefits for PrEP-related support services (as specified in the USPSTF recommendation), such as HIV and STI screening (see Practice Note, Preventive Health Services Under the ACA, Other Than Contraceptives: Use of Reasonable Medical Management). This is because the USPSTF's PrEP recommendation specifies the frequency of certain of these services. (Under the ACA's preventive health services rules, reasonable medical management may be used to determine the frequency of a recommended preventive service only to the extent not specified in the applicable recommendation or guideline.)
Also, when PrEP is medically appropriate for an individual, it would not be reasonable to restrict how often the individual may start PrEP.
However, because the branded version of PrEP is not specified in the USPSTF determination, plans and insurers may:
  • Cover a generic version of PrEP without cost-sharing.
  • Impose cost-sharing on an equivalent branded version.
But plans and issuers also must accommodate any individual for whom a particular PrEP medication (generic or brand name) would be medically inappropriate, as determined by the individual's health provider. This requires a method for waiving cost-sharing (which would otherwise be imposed) for the brand or non-preferred brand version.
Finally, the FAQs include an example of an exceptions process for plans or insurers that use permitted reasonable medical management practices. The exceptions process would allow PrEP to be prescribed and accessed on the same day that a participant or beneficiary receives a negative HIV test or decides to start taking PrEP.

Practical Impact

Plan sponsors and their advisors may be surprised regarding the scope of PrEP-related support services that, under the Departments' FAQs, fall under the June 2019 USPSTF recommendation. Although at least some of the support services are also covered preventive health services on a stand-alone basis, plans and insurers may wish to review how they are handling the listed items (for example, adherence counseling)—particularly given the relatively short nonenforcement period provided under the FAQs.